AGP Picks
View all

Cyprus Healthcare Press
Provided by AGP

Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 21, 2026

Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
34 minutes ago

Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping

Indeterminate GlobeNewswire
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
an hour ago

Myriad Genetics Launches FirstGene® Multiple Prenatal Screen

Indeterminate GlobeNewswire
SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program
an hour ago

SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program

Indeterminate GlobeNewswire
Nelipak Releases 2025 Sustainability Report
an hour ago

Nelipak Releases 2025 Sustainability Report

Indeterminate GlobeNewswire
Philips receives FDA 510(k) clearance for next-generation reusable SpO₂ clip sensor
an hour ago

Philips receives FDA 510(k) clearance for next-generation reusable SpO₂ clip sensor

Indeterminate GlobeNewswire
Exagen to Announce Second Quarter Financial Results on August 4, 2026
an hour ago

Exagen to Announce Second Quarter Financial Results on August 4, 2026

Indeterminate GlobeNewswire
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
an hour ago

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

Indeterminate GlobeNewswire
Revagenix Expands Executive Team, Names Peter Smith, Ph.D., Chief Scientific Officer as Lead Program Enters the Clinic
an hour ago

Revagenix Expands Executive Team, Names Peter Smith, Ph.D., Chief Scientific Officer as Lead Program Enters the Clinic

Indeterminate GlobeNewswire
NeuroSigma Announces U.S. Commercial Launch of Second-Generation Monarch® eTNS System for Pediatric ADHD
an hour ago

NeuroSigma Announces U.S. Commercial Launch of Second-Generation Monarch® eTNS System for Pediatric ADHD

Indeterminate GlobeNewswire
Astera Labs Expands Taurus Family with Industry’s First OCP-Standard Footprint Compatible 3.2T Smart Retimers and Smart Redrivers
an hour ago

Astera Labs Expands Taurus Family with Industry’s First OCP-Standard Footprint Compatible 3.2T Smart Retimers and Smart Redrivers

Indeterminate GlobeNewswire
IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer
an hour ago

IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer

Indeterminate GlobeNewswire
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
an hour ago

OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Indeterminate GlobeNewswire
Just Salad Opens in Willow Grove, Pa.
an hour ago

Just Salad Opens in Willow Grove, Pa.

Indeterminate GlobeNewswire
Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program
an hour ago

Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program

Indeterminate GlobeNewswire
Merakris Therapeutics Awarded NIH Direct-to-Phase II SBIR Grant to Advance MTX-001 for Diabetic Foot Ulcers
an hour ago

Merakris Therapeutics Awarded NIH Direct-to-Phase II SBIR Grant to Advance MTX-001 for Diabetic Foot Ulcers

Indeterminate GlobeNewswire
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
an hour ago

Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market

Indeterminate GlobeNewswire
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
an hour ago

Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal

Indeterminate GlobeNewswire
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's…
an hour ago

Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's…

Indeterminate GlobeNewswire
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
an hour ago

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting

Indeterminate GlobeNewswire
Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity
an hour ago

Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Cyprus Healthcare Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.